Surveillance and early intervention for early HNSCC in ESCC patients

Surveillance and early intervention for early HNSCC in ESCC patients - Surveillance and early intervention for early HNSCC in ESCC patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000011973

Enrollment

700

Registered

2013-10-07

Start date

2013-03-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal squamous cell carinoma head and neck squamous cell carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) newly diagnosed stage I/II/III ESCC treated with definitive treatment 2) absence of synchronous advanced cancer containing HNSCC 3) a follow-up period longer than 6 months

Exclusion criteria

Exclusion criteria: 1) history of ESCC 2) stage IVA / IVB ESCC 3) any history of advanced cancer 4) a follow-up period within 6 months

Design outcomes

Primary

Measure	Time frame
Frequency of the serious adverse events (loss of laryngeal function, death) related to metachronous HNSCC.	—

Secondary

Measure	Time frame
Detection rate of superficial HNSCCs	—

Countries

Japan

Contacts

Public ContactHiroyuki Morimoto

National Cancer Center Hospital East, Kashiwa, Japan Endoscopy division

hmorimot@east.ncc.go.jp04-7133-1111

Outcome results